Author

M. Biswas

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 2 Pharmacology & Toxicology· 2 Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Approach:experimental assay· 3 Organism:human· 3 Approach:statistical model· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

A. E. Levy· 2 shared C. Newton-Cheh· 2 shared K. Tarakji· 2 shared M. A. Rosenberg· 2 shared M. Chung· 2 shared P. A. Noseworthy· 2 shared R. Weber· 2 shared A. Arruda· 1 shared

Activity by Year

2018-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

A. E. Levy

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

KDM6A loss sensitizes human acute myeloid leukemia to PARP and BCL2 inhibition

L. D. Boila, S. Ghosh, S. K. Bandyopadhyay, L. Jin, A. Murison, A. G. X. Zeng, W. Shaikh, S. Bhowmik, S. S. N. A. Muddineni, M. Biswas, S. Sinha, S. S. Chatterjee, N. Mbong, O. I. Gan, A. Bose, , A. Sengupta

This study shows that KDM6A loss in AML increases sensitivity to PARP and BCL2 inhibitors, suggesting a new combination therapy approach for KDM6A-mutant AML.

bioRxiv · Jul 12, 2022 · PreprintCancer Biology

In vitro reconstitution demonstrates the amyloid-beta mediated myelin membrane deformation

M. Saleem, A. Tiwari, S. Pradhan, A. Sannigrahi, S. Jha, K. Chattopadhyay, M. Biswas

This study shows A{beta}-40 induces myelin membrane tubulation in vitro through binding and aggregation, revealing mechanisms of potential neuronal demyelination in Alzheimer's Disease.

bioRxiv · Aug 13, 2021 · PreprintBiophysics

Modeling Protein Association from Homogeneous to Mixed Environments: A Reaction-Diffusion Dynamics Approach

M. Biswas, S. K. Sahu

The paper models protein association in crowded environments with varying crowder properties and finds size is more influential than shape in stabilization.

bioRxiv · Jan 25, 2021Biophysics

Multicenter Analysis of Dosing Protocols for Sotalol Initiation

M. Biswas, A. E. Levy, R. Weber, K. Tarakji, M. Chung, P. A. Noseworthy, C. Newton-Cheh, M. A. Rosenberg

This study analyzes dosing protocols for sotalol initiation in 213 patients, finding that dose adjustment predicts successful initiation, with several clinical factors associated with the need for adjustment.

bioRxiv · Jan 29, 2019Pharmacology & Toxicology

Applications of Machine Learning in Decision Analysis for Dose Management for Dofetilide

A. E. Levy, M. Biswas, R. Weber, K. Tarakji, M. Chung, P. A. Noseworthy, C. Newton-Cheh, M. A. Rosenberg

This study uses machine learning to analyze dose adjustment decisions for dofetilide, finding that reinforcement learning identifies patient characteristics and dosing decisions that minimize discharge failure.

bioRxiv · Jan 27, 2019Pharmacology & Toxicology

Active presynaptic ribosomes in mammalian brain nerve terminals, and increased transmitter release after protein synthesis inhibition

M. S. Scarnati, R. Kataria, M. Biswas, K. G. Paradiso

bioRxiv · Apr 5, 2018Cell Biology